METHYLENE BLUE
Drug
Provepharm Inc.
Total Payments
$101,127
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $101,127 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $101,127 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PVP-2016005 | Provepharm Inc. | $101,127 | 0 |
Top Doctors Receiving Payments for METHYLENE BLUE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Antonio, TX | $101,127 | 1 |
Ad
Manufacturing Companies
- Provepharm Inc. $101,127
Product Information
- Type Drug
- Total Payments $101,127
- Total Doctors 0
- Transactions 1
About METHYLENE BLUE
METHYLENE BLUE is a drug associated with $101,127 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Provepharm Inc..
Payment data is available from 2024 to 2024. In 2024, $101,127 was paid across 1 transactions to 0 doctors.
The most common payment nature for METHYLENE BLUE is "Unspecified" ($101,127, 100.0% of total).
METHYLENE BLUE is associated with 1 research study, including "PVP-2016005" ($101,127).